Zenith Drugs Limited has secured a tender worth ₹4.11 Crore from Karnataka State Medical Supplies Corporation Limited (KSMSCL) for the supply of pharmaceutical products. The order, awarded in the normal course of business, involves the supply of Montelukast and Levocetirizine Syrup and is expected to contribute positively to the company's revenues. This development strengthens the company's position in the institutional pharmaceutical supply segment and underscores the trust reposed by government healthcare agencies in its manufacturing capabilities.

The contract was awarded pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. KSMSCL is a Government of Karnataka undertaking. The company confirmed that the transaction does not fall under related party transactions.

Order Details

The specifics of the awarded tender are outlined below:

The execution of this order is anticipated to enhance Zenith Drugs Limited's association with public healthcare institutions.

Zenith Drugs Limited has established a new mother depot in Bengaluru, Karnataka to enhance its distribution network. The facility became operational on June 08, 2026, as part of the company's strategic expansion under Regulation 30.

The new depot is expected to streamline logistics and improve supply chain efficiency across the region. This development marks a significant step in the company's efforts to strengthen its market presence.

Operational Details

The establishment of the mother depot is aimed at optimizing inventory management and ensuring timely delivery of products. The facility will serve as a central hub for distribution in Karnataka and neighboring areas.

Strategic Implications

By expanding its infrastructure, Zenith Drugs Limited is positioning itself to meet growing demand more effectively. The move is anticipated to bolster the company's competitive edge in the pharmaceutical sector.